Usefulness of the TRPV1 blockade has been demonstrated to be beneficial in pain induced by Herpes zoster, diabetic peripheral neuropathy, bone cancer, arthritis, inflammatory bowel disease and migraine [36], [37], [38], [39], [40]. This evidence concerns the gene TRPV1 and arthritic joint disease.